Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
HeraMED Ltd. ( (AU:HMD) ) has shared an announcement.
HeraMED reported a pivotal December 2025 quarter as it accelerated its US push through two significant commercial agreements: a deal with Philips’ US subsidiary to jointly offer an integrated digital maternity care solution to American hospitals, and a pilot deployment with Florida-based health system Lee Health to roll out its HeraCARE platform across prenatal and postpartum care, including Epic EMR integration and evaluation of clinical and operational outcomes. The company also strengthened its regulatory positioning with Australian Class IIb approval for its HeraBEAT device, advanced platform, data and AI initiatives supported by an expanding dataset of over 167,000 maternal vital measurements, reduced operating cash outflows to their lowest level since 2020 through restructuring, and bolstered its balance sheet via a $3.2 million capital raise to fund near-term US deployments, collectively underpinning a capital-light, scalable commercialisation strategy and enhancing its appeal to hospital partners and investors.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Limited (ASX:HMD) is a medical data and technology company focused on the digital transformation of maternity care. Its core offering is the HeraCARE digital platform, which enables remote patient monitoring, personalised care plans, patient engagement and clinical dashboards across prenatal and postpartum pathways, supported by its HeraBEAT fetal heart rate monitoring device. The company targets hospitals and health systems, with a primary strategic focus on the United States and a growing regulatory and clinical presence in the Australian market.
Average Trading Volume: 917,116
Technical Sentiment Signal: Buy
Current Market Cap: A$48.16M
See more data about HMD stock on TipRanks’ Stock Analysis page.